We have become aware of an individual who is falsely representing themselves as a member of the Celerion HR team. Please be cautious when responding to any communication that purports to come from Celerion. All email communication from Celerion will come from an email address appended @celerion.com. No other addresses are legitimate. #hr
Celerion
制药业
Lincoln，NE 17,202 位关注者
Celerion Can Take You from First-In-Human through Proof-of-Concept.
关于我们
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines. With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings. Our operations are strategically located in: Lincoln, Nebraska (Corporate Headquarters) Philadelphia, Pennsylvania Phoenix, Arizona Belfast, Northern Ireland,UK Zurich, Switzerland Vienna, Austria Richmond, Virginia Montreal, Quebec, Canada For more information, visit: www.celerion.com
- 网站
-
https://www.celerion.com
Celerion的外部链接
- 所属行业
- 制药业
- 规模
- 1,001-5,000 人
- 总部
- Lincoln，NE
- 类型
- 私人持股
- 创立
- 2010
- 领域
- Applied Translational Medicine、Global Clinical Research (Phase I and II, NDA-enabling clinical pharmacology)、Data Management and Biometrics、Global Bioanalytical Services (discovery through late phase)、Drug Development Services和Global Clinical Development
地点
Celerion员工
动态
-
Partner with us for exceptional clinical trial outcomes through advanced flow cytometry. From customizable panels to precise pharmacodynamic endpoints, our expertise drives your success. Excellence begins with reliable data! Learn more: https://lnkd.in/e95UG7vC #FlowCytometry #ClinicalTrials #Pharmacodynamic
-
-
Celerion has the experience and expertise to support oligonucleotide drug development. Read about our experience with multiple modalities and routes of oligonucleotide administration. Read our Fact Sheet: https://lnkd.in/eERmq39y #biologics #oligonuleotides #drugdevelopment
-
-
Celerion offers full-service support for PK bridging studies. Leverage our decades of experience to optimize study design. Our streamlined process delivers an accelerated study start-up, efficient study conduct, and rapid database lock. Learn about our Clinical Pharmacology Services: https://lnkd.in/gdvGTfkt Expert biosimilar support: https://lnkd.in/eGjzF3g #BridgingPK #Celerion
-
-
We generate bespoke strategies that minimize the time to key go/no-go decisions by leveraging our 650-bed capacity, co-localized bioanalysis services and innovative technology platforms to enrich data collection and analysis and to expedite data delivery for our clients. Learn what makes Celerion a premier early phase CRO: https://lnkd.in/eSk8Ynf #CRO #ClinicalTrials #Bioanalysis
-
-
The rise of GLP-1 receptor agonists, such as semaglutide and tirzepatide, has revolutionized weight loss treatments—but how do they impact the absorption of other medications? In this video, Celerion’s experts, Sabina Paglialunga, PhD and Aernout van Haarst, explore the effects of delayed gastric emptying on drug-drug interactions and why evaluating these interactions early in development is critical. #Celerion #GLP1 #ClinicalResearch #DrugDevelopment #Pharmacokinetics
-
Join Celerion for an evening of insightful discussions and dining as we explore key bioanalytical challenges in cell and gene therapy development with Johannes Stanta, PhD, Scientific Director at Celerion. Event Details: March 19, 2025 The Lexington, Boston, MA 6:00 p.m. EDT – Networking & Cocktails 7:00 p.m. EDT – Private Dining & Discussion Discussion Highlights: -Emerging trends in bioanalysis for cell & gene therapies -Sample stability best practices during shipment -PBMC logistics and standardization in clinical trials -Patient enrollment strategies with optimized screening assays -Future innovations in decentralized and patient-centric sampling Engage with industry leaders in an exclusive, informal setting while gaining valuable scientific insights. Seats are limited to professionals in biotech/pharma companies! Register now to secure your place: https://lnkd.in/efZMNVAN #Celerion #CellAndGeneTherapy #Bioanalysis #ClinicalResearch #PharmaEvents #BostonNetworking
-
-
See how our experience, expertise and built-in efficiencies can support your mAb drug studies in healthy volunteers. Read more: https://lnkd.in/eaFCexAV #biologics #mAb #drugdevelopment
-
-
Celerion is attending a breakfast networking session at Pennsylvania Biotechnology Center (PABC) in Doylestown, PA this coming Thursday, March 13th. If you're interested in attending please reach out to Mike Lindenmuth at [email protected].
-